The company reports first sales in Austria for its CADScor System for early rule-out of CAD.
“By using the unique technology provided by Acarix and the CADScor System I can limit the number of patients that will be referred to coronary angiography. This will help shorten waiting lists and add value for both patients and the healthcare system. We have lowered the numbers of patients that actually have to be exposed to further examinations and thereby saving expenses to the hospital ” says Dr Werner Kommer, Facharzt für Innere Medizin und Kardiologie in Wolkersdorf, Austria, in Acarix’s press release.
“Our entry to the Austrian market marks a major step forward,” says Per Persson, Chief Commercial Officer at Acarix. “Our three new accounts confirm the benefits of the technology and its suitability for both private and public healthcare settings. We look forward to building on this throughout the Austrian market.”
